Harrow, Inc. (HROW)
36.89
-0.38
(-1.02%)
USD |
NASDAQ |
Aug 31, 16:00
36.89
0.00 (0.00%)
After-Hours: 20:00
Harrow Cash from Operations (Annual) : 43.86M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 43.86M |
| December 31, 2024 | -22.20M |
| December 31, 2023 | 3.84M |
| December 31, 2022 | 1.705M |
| December 31, 2021 | 5.082M |
| December 31, 2020 | -1.10M |
| December 31, 2019 | 0.95M |
| December 31, 2018 | 0.687M |
| December 31, 2017 | -8.803M |
| December 31, 2016 | -11.22M |
| December 31, 2015 | -11.14M |
| Date | Value |
|---|---|
| December 31, 2014 | -7.055M |
| December 31, 2013 | -4.439M |
| December 31, 2012 | -1.901M |
| December 31, 2011 | -0.2912M |
| December 31, 2010 | -2.298M |
| December 31, 2009 | -3.571M |
| December 31, 2008 | -2.534M |
| December 31, 2007 | -1.764M |
| December 31, 2006 | -0.0557M |
| December 31, 2005 | -0.0888M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Viatris, Inc. | 2.316B |
| Zevra Therapeutics, Inc. | -1.598M |
| Indivior Pharmaceuticals, Inc. | -27.00M |
| Liquidia Corp. | -35.69M |
| 60 Degrees Pharmaceuticals, Inc. | -6.849M |